Search Results 711-720 of 19780 for ast

  1. Non-Alcoholic Fatty Liver Disease Progression Prevention Using Lisinopril - Mayo Clinic

    syndrome. - Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamic pyruvic ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    ast biopsy, Breast surgery, Double mastectomy, Prophylactic mastectomy, Breast duct excision, Lymph node biopsy, Breast abscess drainage, Radioactive seed ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    ast biopsy, Breast surgery, Double mastectomy, Prophylactic mastectomy, Breast duct excision, Lymph node biopsy, Breast abscess drainage, Radioactive seed ...

  4. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

    ALT and AST ≤ 3 × ULN unless liver metastases are present in which case patients are included; if ALT and AST ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN; OR ...

  5. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    AST or ALT >5 times UNL; For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis ...

  6. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Aspartate aminotransferase (AST) ≤ 2.5 x upper limits of normal (ULN); Fasting serum triglycerides ≤ 200 mg/dL; Serum cholesterol ≤ 300 mg/dL; Fasting serum ...

  7. Global Trial in APG2575 for Patients With CLL/​SLL - Mayo Clinic

    * Aspartate aminotransferase (AST) ≤ 2.5 x the institutional ULN value * Alanine aminotransferase (ALT) ≤ 2.5 x the institutional ULN value ...

  8. CD19-Directed CAR-T Cell Therapy For The Treatment Of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3 x ULN;; PT/INR and/or aPTT ≤ 1.5 x ULN OR if patient is receiving anticoagulant therapy ...

  9. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

    - AST (SGOT) and ALT (SGPT) ≤2.5 × ULN - Coagulation - International normalized ratio (INR) OR prothrombin time (PT) Activated partial thromboplastin time ...

  10. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

    ALT or AST > 3 times the upper limit of normal range, or severe hepatic impairment;; Hemoglobin < 100 g/L;; NT-proBNP ≥ 500 pg/mL. If one of these criteria ...